| Nancy I Linneman, MD | |
|
155 Crystal Run Rd, Middletown, NY 10941-4028 | |
| (845) 703-6999 | |
| (845) 703-6297 |
| Full Name | Nancy I Linneman |
|---|---|
| Gender | Female |
| Speciality | Pulmonary Disease |
| Experience | 34 Years |
| Location | 155 Crystal Run Rd, Middletown, New York |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003816604 | NPI | - | NPPES |
| 01753548 | Medicaid | NY |
| Facility Name | Location | Facility Type |
|---|---|---|
| Garnet Health Medical Center | Middletown, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Crystal Run Healthcare Physicians Llp | 6901792696 | 395 |
News Archive
Women being treated for breast cancer with aromatase inhibitors may experience extremely low estrogen levels resulting in a wide variety of side effects that a typical postmenopausal woman without cancer may not experience.
EpiCept Corporation today announced operating and financial results for the fourth quarter and year ended December 31, 2009, and provided an update on Ceplene® and several of the Company's key product candidates.
Quality Systems, Inc. announced today that its Dental Division's NextDDS solution earned the American Business Award (ABA) for best ad campaign in the health products and services category.
Spectral Diagnostics Inc., a company developing products for the treatment of sepsis, today announced that the U.S. Food and Drug Administration has granted Investigational Device Exemption (IDE) approval for Toraymyxin, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream, allowing the Company to conduct a pivotal trial in the United States.
› Verified 5 days ago
| Entity Name | Crystal Run Healthcare Physicians Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952376410 PECOS PAC ID: 6901792696 Enrollment ID: O20040227000791 |
News Archive
Women being treated for breast cancer with aromatase inhibitors may experience extremely low estrogen levels resulting in a wide variety of side effects that a typical postmenopausal woman without cancer may not experience.
EpiCept Corporation today announced operating and financial results for the fourth quarter and year ended December 31, 2009, and provided an update on Ceplene® and several of the Company's key product candidates.
Quality Systems, Inc. announced today that its Dental Division's NextDDS solution earned the American Business Award (ABA) for best ad campaign in the health products and services category.
Spectral Diagnostics Inc., a company developing products for the treatment of sepsis, today announced that the U.S. Food and Drug Administration has granted Investigational Device Exemption (IDE) approval for Toraymyxin, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream, allowing the Company to conduct a pivotal trial in the United States.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Nancy I Linneman, MD 155 Crystal Run Rd, Middletown, NY 10941-4028 Ph: (845) 703-6999 | Nancy I Linneman, MD 155 Crystal Run Rd, Middletown, NY 10941-4028 Ph: (845) 703-6999 |
News Archive
Women being treated for breast cancer with aromatase inhibitors may experience extremely low estrogen levels resulting in a wide variety of side effects that a typical postmenopausal woman without cancer may not experience.
EpiCept Corporation today announced operating and financial results for the fourth quarter and year ended December 31, 2009, and provided an update on Ceplene® and several of the Company's key product candidates.
Quality Systems, Inc. announced today that its Dental Division's NextDDS solution earned the American Business Award (ABA) for best ad campaign in the health products and services category.
Spectral Diagnostics Inc., a company developing products for the treatment of sepsis, today announced that the U.S. Food and Drug Administration has granted Investigational Device Exemption (IDE) approval for Toraymyxin, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream, allowing the Company to conduct a pivotal trial in the United States.
› Verified 5 days ago
Dr. Aamir Masood Gilani, M.D Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 707 E Main St, Middletown, NY 10940 Phone: 845-333-7575 Fax: 845-333-7202 | |
Dr. Dahlia Banerji, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 111 Maltese Dr, Middletown, NY 10940 Phone: 845-342-4774 | |
Rafeel O Syed, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 155 Crystal Run Rd, Middletown, NY 10941 Phone: 845-703-6999 Fax: 845-703-6297 | |
Dr. Corina Cristescu, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 111 Maltese Dr, Middletown, NY 10940 Phone: 845-342-4774 Fax: 845-818-7555 | |
Dr. Robert Lewis Douglas, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 210 E Main St, Middletown, NY 10940 Phone: 845-342-5681 Fax: 845-342-0470 | |
Peggy Nelson, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 155 Crystal Run Rd, Middletown, NY 10941 Phone: 845-703-6999 Fax: 845-703-6297 |